23/09/2026 - Four new sucrosomial® products for the italian market: pharmanutra accelerates innovation

• "Apportal® Master", developed for the senior segment, and "Apportal® Junior", designed to provide younger individuals with energy and restorative support.
• "Sucrosomial® Creatine" and "Pre Start Shot", formulated to prepare the body for exertion, support training and help athletes manage physical stress.

Pisa, 23 September 2026 - Pharmanutra S.p.A. (MTA; Ticker PHN), a company specialised in iron- and mineral-based nutritional supplements and medical devices for muscles and joints, is expanding its product portfolio with the launch in Italy of new food supplements in the Apportal® and Cetilar® Nutrition lines, all developed with Sucrosomial® Technology.

In the Apportal® line, two new products will be available from 24 September: Apportal® Master, designed to support physical and mental energy and help counteract oxidative stress, and Apportal® Junior, the new evolution of the well-known Apportal® Vital, created to meet the needs of younger individuals when the body requires energy and strength.

Apportal® Master is a food supplement designed for people over 50 seeking support for neurocognitive wellbeing. Each sachet contains 24 nutrients, including creatine, vitamin C, beta-carotene, royal jelly, NADH and zinc, as well as vitamin D3 and vitamin B12 in Sucrosomial® form - a delivery system conceived and patented by Pharmanutra to improve the tolerability and absorption of vitamins, minerals and phytoextracts. Combined with five minerals - also developed with Sucrosomial® Technology (selenium, iron, zinc, magnesium and iodine) - the nutrients in Apportal® Master provide an energy boost that supports the body's cognitive and muscular functions. The product is therefore recommended during convalescence, seasonal changes and periods of physical and mental fatigue.

asthenia, such as during convalescence and seasonal changes. Apportal® Junior supports the normal function of the immune system while providing a tonic, energising and restorative action.

With the addition of Apportal® Master and Apportal® Junior, alongside Apportal® and Apportal® Boost, the Apportal® line now comprises four solutions. Launched in 2018, the line was the first complete nutritional supplement to combine 19 nutrients in a single sachet, including five Sucrosomial® minerals, helping to reduce tiredness and fatigue and contribute to the normal function of the immune system.

Sucrosomial® Creatine is a creatine monohydrate-based food supplement (50% creatine monohydrate and 50% Sucrosomial® creatine monohydrate), designed to provide targeted support for those pursuing high performance and seeking to improve output during the most demanding workouts. The use of Sucrosomial® Technology, combined with creatine for the first time, is key to ensuring excellent results in terms of nutrient stability and absorption.

Pre Start Shot is a liquid pre-workout food supplement containing amino acids, B vitamins, Sucrosomial® Selenium and Sucrosomial® Chromium. It is ideal for preparing the body for exertion, supporting intense training sessions and helping the body manage physical stress. Its formula combines key amino acids and derivatives, including Sucrosomial® vitamin B12 (UltraB12®), Sucrosomial® Selenium (UltraSel®) and Sucrosomial® Chromium (UltraChrome®).

The new products, also available from 24 September, will further enrich the extensive Cetilar® Nutrition range, designed to provide targeted, technologically advanced supplementation in support of sports performance and recovery. All Cetilar® Nutrition products are also Play Sure Doping Free certified, ensuring safety even in competitive sport.

Andrea Lacorte, Chairman of Pharmanutra S.p.A., commented: "The launch of these four new products is a source of great pride and enthusiasm for us, as it confirms the extraordinary contribution that Sucrosomial® Technology can make to the development of new solutions. It enables us to create highly scientific formulations that are truly specific to individual target groups, while maintaining the highest levels of nutrient absorption and tolerability, with a unique and distinctive synergistic effect among the various components. Our ongoing focus is to apply the uniqueness of our technology to different nutrients, always placing science first. This increasingly

makes us a reference point and a valuable partner for the medical and scientific community. Sucrosomial® Creatine deserves a special mention because, for the first time, we have combined our technology with creatine, with a level of scientific rigour and quality of which we are very proud. We believe the product will be truly revolutionary in its segment, also because it was developed through dialogue with our partners and sports professionals who, being accustomed to high-performance contexts, have helped identify what can genuinely be useful during moments of high-intensity physical exertion. Pharmanutra is currently in a phase of major development, and the ability to apply our technology across many areas offers highly significant potential for new products, which we will launch both in Italy and in international markets as early as 2027".

Founded in 2003 in Pisa by Andrea and Roberto Lacorte, Pharmanutra is the holding company of an international Group engaged in the research, development, and commercialization of nutritional supplements, medical devices, and patented raw materials. A leader in iron-based supplements through its Sucrosomial® Technology (SiderAL® and Apportal®), and an emerging player in medical devices for mobility (Cetilar®), the Group internally manages the entire value chain and holds a solid portfolio of patents, brands, and clinical evidence.

Pharmanutra operates in over 80 countries, with subsidiaries in the USA and Spain, and also includes Akern S.r.l. (bioimpedance analysis) and Athletica Cetilar S.r.l. (sports medicine)

pharmanutragroup.com pharmanutra.it

For further information:

Via Campodavela 1 - 56122 Pisa

Tel. +39 050 7846500

s.delre@pharmanutra.it investorrelations@pharmanutra.it

press@calabughi.com

Via Santa Radegonda, 16 - 20121 Milano Tel. +39 02 83635708

mrusso@sprianocommunication.com

ctronconi@sprianocommunication.com